↓ Skip to main content

A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, March 2021
Altmetric Badge

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
60 Mendeley